This assay uses a model of antigen presentation in vitro in the form of a dengue EDIII peptide pool that is presented on the MHC molecules of the antigen-presenting cells (APCs) to the antigen-specific T cells generated during DSV4 immunization. This evidence concerns the gene HLA-C and dengue disease.